Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.
about
Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of IndiaImpact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients.New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010)Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.Transmitted HIV drug resistance in treatment-naive Romanian patientsVirological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of IndiaHIV-1 nonsubtype B distribution across certain resource-rich countries
P2860
Q33583299-DF6D48F0-7052-4CC0-A008-9A6CFD8008EBQ33683115-13D9AFF7-CFF0-4BC0-BDB6-7BB5B379E8B2Q33786428-AD3FBFCD-3D61-432F-9F0F-D631EE5565E6Q35206389-120CFEB4-62A7-4F5A-B526-83ED449107F9Q36347325-DBD2B494-4501-4D30-8EA1-14DDA5FE0276Q36429586-C07D9931-B284-41EB-B737-133A1E912332Q37189622-A5CF59AC-B16E-495F-A340-48A11F73BB93Q37216229-22D4B02D-67E5-49AB-AC46-2F92A68B0591Q37495405-F7A078DA-26B2-41C7-8C18-5EA49869F6B4Q37613239-69E84B0A-1ABD-42BD-AB24-C478FFE2F7F7Q38726300-7B1031E2-1AC0-4858-8BD6-CABC203CCC11Q42159090-2E6E1909-CE84-496C-BFF2-2247A8521B3AQ56965171-586D14F5-0373-485A-9B86-8843EDEBC6DCQ58485636-0637B469-4AE0-4FAE-9A92-B8E431C6DEC3
P2860
Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@en
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@nl
type
label
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@en
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@nl
prefLabel
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@en
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@nl
P2093
P1476
Comparison of drug resistance ...... infected with HIV-1 subtype B.
@en
P2093
Brigitte Montes
Jacques Reynes
Laurence Vergne
Michel Segondy
P304
P356
10.1097/00126334-200404010-00001
P407
P577
2004-04-01T00:00:00Z